Skip to content
OpenCapital
Get started

Standard BioTools Inc. LAB Q4 2024 Annual earnings

Reported February 26, 2025 · After market close

Revenue$46.7MBeat by $3.7M
EPS-$0.05Beat by $0.02
Revenue estimate$43.0M
EPS estimate-$0.07

Next report

Aug 5, 2026 (In 1 week)
Revenue estimate$20.8M
EPS estimate-$0.01

Versus estimates

Revenue

Q1 2026$21.1MBeat by $3.3MQ4 2025$23.8MBeat by $5.3MQ3 2025$19.6MBeat by $1.1MQ2 2025$21.8MMiss by $19.1MQ1 2025$40.8MBeat by $1.6M
Q4 2024$46.7MBeat by $3.7M

Diluted EPS

Q1 2026-$0.02In lineQ4 2025$0.06Beat by $0.09Q3 2025-$0.04Miss by $0.02Q2 2025-$0.04In lineQ1 2025-$0.04In line
Q4 2024-$0.05Beat by $0.02

Ask the moment Standard BioTools Inc. reports.

Connect your AI and ask the moment the filing drops. It reads the release, surfaces what management said, and gives you its own read.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

When did Standard BioTools Inc. report Q4 2024 earnings?
Standard BioTools Inc. (LAB) reported Q4 2024 earnings on February 26, 2025 after market close.
What were Standard BioTools Inc.'s Q4 2024 revenue and EPS?
Standard BioTools Inc. reported revenue of $46.7M and eps of $-0.05 for Q4 2024.
Did Standard BioTools Inc. beat estimates in Q4 2024?
Revenue beat the consensus estimate of $43.0M by $3.7M. EPS beat the consensus estimate of $-0.07 by $0.02.
Where can I find Standard BioTools Inc.'s Q4 2024 SEC filings?
You can read the 10-K periodic report (0000950170-25-036608) directly on SEC EDGAR. The filing index links above go to sec.gov.